Molecular mimicry, microbial infection, and autoimmune disease: evolution of the concept
- PMID: 16329189
- PMCID: PMC7120699
- DOI: 10.1007/3-540-30791-5_1
Molecular mimicry, microbial infection, and autoimmune disease: evolution of the concept
Abstract
Molecular mimicry is defined as similar structures shared by molecules from dissimilar genes or by their protein products. Either several linear amino acids or their conformational fit may be shared, even though their origins are separate. Hence, during a viral or microbe infection, if that organism shares cross-reactive epitopes for B or T cells with the host, then the response to the infecting agent will also attack the host, causing autoimmune disease. A variation on this theme is when a second, third, or repeated infection(s) shares cross-reactive B or T cell epitopes with the first (initiating) virus but not necessarily the host. In this instance, the secondary infectious agents increase the number of antiviral/antihost effector antibodies or T cells that potentiate or precipitate the autoimmune assault. The formation of this concept initially via study of monoclonal antibody or clone T cell cross-recognition in vitro through its evolution to in vivo animal models and to selected human diseases is explored in this mini-review.
References
-
- Brewerton D., Caffrey M., Hart F., James D., Nichols A., Sturrock R. Ankylosing spondylitis and HLA B27. Lancet. 1973;i:904–907. - PubMed
-
- Cunningham M.W., Fujinami R.S., editors. Molecular mimicry. Washington DC: ASM Press; 2000.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
